Literature DB >> 19403796

Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors.

Carmen Mazzola1, Julie Medalie, Maria Scherma, Leigh V Panlilio, Marcello Solinas, Gianluigi Tanda, Filippo Drago, Jean Lud Cadet, Steven R Goldberg, Sevil Yasar.   

Abstract

Inhibitors of fatty acid amide hydrolase (FAAH) increase endogenous levels of anandamide (a cannabinoid CB(1)-receptor ligand) and oleoylethanolamide and palmitoylethanolamide (OEA and PEA, ligands for alpha-type peroxisome proliferator-activated nuclear receptors, PPAR-alpha) when and where they are naturally released in the brain. Using a passive-avoidance task in rats, we found that memory acquisition was enhanced by the FAAH inhibitor URB597 or by the PPAR-alpha agonist WY14643, and these enhancements were blocked by the PPAR-alpha antagonist MK886. These findings demonstrate novel mechanisms for memory enhancement by activation of PPAR-alpha, either directly by administering a PPAR-alpha agonist or indirectly by administering a FAAH inhibitor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19403796      PMCID: PMC2683005          DOI: 10.1101/lm.1145209

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  41 in total

Review 1.  Cannabinoid receptors and endocannabinoids: evidence for new players.

Authors:  Ken Mackie; Nephi Stella
Journal:  AAPS J       Date:  2006-04-28       Impact factor: 4.009

2.  Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.

Authors:  Stephen A Varvel; Laura E Wise; Floride Niyuhire; Benjamin F Cravatt; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2006-10-18       Impact factor: 7.853

3.  Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice.

Authors:  Rudolph Marsch; Elisabeth Foeller; Gerhard Rammes; Mirjam Bunck; Manfred Kössl; Florian Holsboer; Walter Zieglgänsberger; Rainer Landgraf; Beat Lutz; Carsten T Wotjak
Journal:  J Neurosci       Date:  2007-01-24       Impact factor: 6.167

Review 4.  Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).

Authors:  Daniele Piomelli; Giorgio Tarzia; Andrea Duranti; Andrea Tontini; Marco Mor; Timothy R Compton; Olivier Dasse; Edward P Monaghan; Jeff A Parrott; David Putman
Journal:  CNS Drug Rev       Date:  2006

5.  Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.

Authors:  Jesse LoVerme; Roberto Russo; Giovanna La Rana; Jin Fu; Jesse Farthing; Giuseppina Mattace-Raso; Rosaria Meli; Andrea Hohmann; Antonio Calignano; Daniele Piomelli
Journal:  J Pharmacol Exp Ther       Date:  2006-09-22       Impact factor: 4.030

Review 6.  Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.

Authors:  S E O'Sullivan
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

7.  Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.

Authors:  Y Sun; S P H Alexander; M J Garle; C L Gibson; K Hewitt; S P Murphy; D A Kendall; A J Bennett
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

8.  Exposure to marijuana smoke impairs memory retrieval in mice.

Authors:  Floride Niyuhire; Stephen A Varvel; Billy R Martin; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2007-06-22       Impact factor: 4.030

9.  The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.

Authors:  Roberto Russo; Jesse Loverme; Giovanna La Rana; Timothy R Compton; Jeff Parrott; Andrea Duranti; Andrea Tontini; Marco Mor; Giorgio Tarzia; Antonio Calignano; Daniele Piomelli
Journal:  J Pharmacol Exp Ther       Date:  2007-04-05       Impact factor: 4.030

Review 10.  Biochemistry and pharmacology of endovanilloids.

Authors:  Katarzyna Starowicz; Santosh Nigam; Vincenzo Di Marzo
Journal:  Pharmacol Ther       Date:  2007-02-02       Impact factor: 12.310

View more
  60 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors.

Authors:  Antonio Luchicchi; Salvatore Lecca; Stefano Carta; Giuliano Pillolla; Anna L Muntoni; Sevil Yasar; Steven R Goldberg; Marco Pistis
Journal:  Addict Biol       Date:  2010-05-11       Impact factor: 4.280

3.  Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.

Authors:  Mei Qin; Zachary Zeidler; Kristen Moulton; Leland Krych; Zengyan Xia; Carolyn B Smith
Journal:  Behav Brain Res       Date:  2015-05-12       Impact factor: 3.332

Review 4.  Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.

Authors:  Antonio Luchicchi; Marco Pistis
Journal:  Mol Neurobiol       Date:  2012-07-17       Impact factor: 5.590

5.  Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation.

Authors:  Erin M Rock; Cheryl L Limebeer; Jordan M Ward; Arianne Cohen; Katherine Grove; Micah J Niphakis; Benjamin F Cravatt; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2015-08-23       Impact factor: 4.530

Review 6.  Physical activity and the endocannabinoid system: an overview.

Authors:  Mirko Tantimonaco; Roberta Ceci; Stefania Sabatini; Maria Valeria Catani; Antonello Rossi; Valeria Gasperi; Mauro Maccarrone
Journal:  Cell Mol Life Sci       Date:  2014-02-14       Impact factor: 9.261

7.  Tetracosahexaenoylethanolamide, a novel N-acylethanolamide, is elevated in ischemia and increases neuronal output.

Authors:  Lin Lin; Adam H Metherel; Mathieu Di Miceli; Zhen Liu; Cigdem Sahin; Xavier Fioramonti; Carolyn L Cummins; Sophie Layé; Richard P Bazinet
Journal:  J Lipid Res       Date:  2020-08-21       Impact factor: 5.922

8.  Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.

Authors:  Cheryl L Limebeer; Rehab A Abdullah; Erin M Rock; Elizabeth Imhof; Kai Wang; Aron H Lichtman; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2013-09-17       Impact factor: 4.530

9.  The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury.

Authors:  Flaubert Tchantchou; Laura B Tucker; Amanda H Fu; Rebecca J Bluett; Joseph T McCabe; Sachin Patel; Yumin Zhang
Journal:  Neuropharmacology       Date:  2014-06-14       Impact factor: 5.250

Review 10.  Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.